GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Advanced Life Sciences Holdings, Inc. (ADLS) [hlAlert]

Rating:
Mkt Outperform
ADLS
down 93.75 %

Advanced Life Sciences Holdings, Inc. (ADLS) rated Mkt Outperform by Rodman & Renshaw

Posted on: Monday,  Jan 26, 2009  9:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS) on 01/26/2009, when the stock price was
$0.32. Since then, Advanced Life Sciences Holdings, Inc. has lost 93.75% as of 08/26/2015's recent price of $0.02.
If you would have followed this Rodman & Renshaw's recommendation on ADLS, you would have lost 93.75% of your investment in 2403 days.

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation using its platform in natural products and chemical proteomics coupled with expertise in drug development. The company's lead candidate, cethromycin, is a novel ketolide antibiotic in late-stage clinical development for the treatment of respiratory tract infections.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2009 9:25 AM Buy
None
0.32
as of 12/31/2009
1 Week down  -28.07 %
1 Month up  20.58 %
3 Months down  -47.43 %
1 YTD down  -93.59 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy